Latifa Bakiri1,2,*, Sebastian C. Hasenfuss2,§, Ana Guío-Carrión2,#, Martin K. Thomsen3, Peter Hasselblatt4 and Erwin F. Wagner1, 5,*1 Laboratory Genes and Disease, Department of Laboratory Medicine, Medical University of Vienna (MUW), Vienna, Austria.2 Genes, Development and Disease Group, CNIO - National Cancer Research Centre, Madrid, Spain.3 Department of Biomedicine, University of Aarhus, Denmark.4 Department of Medicine II, University Hospital and Faculty of Medicine, Freiburg, Germany.5 Laboratory Genes and Disease, Department of Dermatology, Medical University of Vienna (MUW), Vienna, Austria.§ Current address: Beam Therapeutics, Cambridge, Massachusetts, USA.# Current address: CNIC - National Center for Cardiovascular Research, Madrid, Spain.* Corresponding authors: Latifa Bakiri & Erwin F. Wagner, Department of Laboratory Medicine and Department of Dermatology, Medical University of Vienna, Lazarettgasse 14, A-1090 Vienna, Austria.Tel: +43-1-40400-73506.e-mail: [email protected], [email protected] title: c-Jun/Fra-2 dimers in liver cancerThis is a prefinal, unformatted author copy of a manuscript published in PNAS: PMID: 38657045 / 'https://doi.org/10.1073/pnas.2404188121 Keywords : c-Jun/Fra-2, AP-1, HCC, mouse models, c-Myc